Zdrowie i gospodarka · 08/12/2008

FDA Establishes Risk Communication Advisory Committee to Improve Prescription Drug Information

The US Food and Drug Administration (FDA) is seeking input from stakeholders and the public on improving the communication of information about prescription drugs to patients, with a meeting scheduled to take place. The meeting will consider the use of Patient-Reported Intolerance Symptoms (PPIs) in drug labeling, and background material will be made available to the public prior to the meeting.